Open AccessSAT-175 TOLVAPTAN TREATMENT IN POLYCYSTIC KIDNEY DISEASE
Author(s) -
Sibel Gökçay Bek,
Necmi Eren,
Bora Uslu,
Şenay Balcı,
Betül Kalender
Publication year - 2020
Publication title -
kidney international reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2020.02.187
Subject(s) - tolvaptan , medicine , autosomal dominant polycystic kidney disease , polycystic kidney disease , kidney , disease , cyst , vasopressin antagonists , vasopressin , kidney disease , urology , arginine vasopressin receptor 2 , pathology , receptor , antagonist
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom